Review




Structured Review

Simulations Plus Inc computer modeling software gastroplustm
Computer Modeling Software Gastroplustm, supplied by Simulations Plus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastroplustm+software/computer+modeling+software+gastroplustm/pm28321831-42-1-7
Average 90 stars, based on 1 article reviews
computer modeling software gastroplustm - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Software:

Article Title: The impact of gastric pH, volume, and emptying on the food effect of ziprasidone oral absorption.
Article Snippet: In a recent food effect clinical study, the authors concluded that a meal consisting of ≥500 kcal, regardless of fat content, produced the maximal bioavailability for ziprasidone.. Using GastroPlusTM, a commercially available pharmacokinetic simulation software, a semiphysiological model—a kind of physiologically based pharmacokinetic (PBPK) absorption model—was developed that could predict the concentration-time profiles when ziprasidone was administered with any one of the five test meals or fasting.. Ziprasidone intravenous pharmacokinetics and oral absorption permeability were determined from clinical studies following the intravenous and duodenal infusion of ziprasidone to volunteers.



Similar Products

90
Simulations Plus Inc gastroplustm software
Gastroplustm Software, supplied by Simulations Plus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastroplustm+software/gastroplustm+software/pm40281717-76-0-7
Average 90 stars, based on 1 article reviews
gastroplustm software - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Simulations Plus Inc gastroplustm software version 9.8.2000
Gastroplustm Software Version 9.8.2000, supplied by Simulations Plus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastroplustm+software/gastroplustm+software/pmc12024831-124-0-4
Average 90 stars, based on 1 article reviews
gastroplustm software version 9.8.2000 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Simulations Plus Inc dynamic pbpk modeling software gastroplustm version 9.9
Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and <t>PBPK</t> model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.
Dynamic Pbpk Modeling Software Gastroplustm Version 9.9, supplied by Simulations Plus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastroplustm+software/pbpk+model+commercial+software+gastroplus/pmc11983545-113-16-23
Average 90 stars, based on 1 article reviews
dynamic pbpk modeling software gastroplustm version 9.9 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Simulations Plus Inc pbpk modeling software gastroplustm version 9.8.2
Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and <t>PBPK</t> model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.
Pbpk Modeling Software Gastroplustm Version 9.8.2, supplied by Simulations Plus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastroplustm+software/pbpk+model+commercial+software+gastroplus/pm40122328-71-52-59
Average 90 stars, based on 1 article reviews
pbpk modeling software gastroplustm version 9.8.2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Simulations Plus Inc gastroplustm software version 9.7
Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and <t>PBPK</t> model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.
Gastroplustm Software Version 9.7, supplied by Simulations Plus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastroplustm+software/gastroplustm+software/pmc11897275-155-20-24
Average 90 stars, based on 1 article reviews
gastroplustm software version 9.7 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Simulations Plus Inc gastroplustm software version 9.6
Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and <t>PBPK</t> model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.
Gastroplustm Software Version 9.6, supplied by Simulations Plus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastroplustm+software/gastroplustm+software/pmc11279950-150-10-14
Average 90 stars, based on 1 article reviews
gastroplustm software version 9.6 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.

Journal: Frontiers in Pharmacology

Article Title: High vs. low vancomycin therapeutic concentrations in periprosthetic joint infection: A retrospective cohort analysis

doi: 10.3389/fphar.2025.1555276

Figure Lengend Snippet: Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.

Article Snippet: To assess pharmacokinetics and tissue distribution of vancomycin in PJI patients, we employed the commercially available dynamic PBPK modeling software GastroPlusTM version 9.9 (Simulations Plus, Inc.) to construct a stepwise model as previously described ( ).

Techniques: Concentration Assay, Clinical Proteomics

The model to predict vancomycin concentrations in the red marrow, yellow marrow and kidney: (A) Observed and PBPK model simulated concentrations in plasma, red marrow, and yellow marrow in the HC group. (B) Observed and PBPK model simulated concentrations in plasma, red marrow, and yellow marrow in the LC group. (C) Observed and PBPK model simulated concentrations in plasma and kidney in the HC group. (D) Observed and PBPK model simulated concentrations in plasma and kidney in the LC group.

Journal: Frontiers in Pharmacology

Article Title: High vs. low vancomycin therapeutic concentrations in periprosthetic joint infection: A retrospective cohort analysis

doi: 10.3389/fphar.2025.1555276

Figure Lengend Snippet: The model to predict vancomycin concentrations in the red marrow, yellow marrow and kidney: (A) Observed and PBPK model simulated concentrations in plasma, red marrow, and yellow marrow in the HC group. (B) Observed and PBPK model simulated concentrations in plasma, red marrow, and yellow marrow in the LC group. (C) Observed and PBPK model simulated concentrations in plasma and kidney in the HC group. (D) Observed and PBPK model simulated concentrations in plasma and kidney in the LC group.

Article Snippet: To assess pharmacokinetics and tissue distribution of vancomycin in PJI patients, we employed the commercially available dynamic PBPK modeling software GastroPlusTM version 9.9 (Simulations Plus, Inc.) to construct a stepwise model as previously described ( ).

Techniques: Clinical Proteomics